Health ❯ Healthcare

Drug Pricing

Market Access Cost Reduction Strategies Market Competition Pharmaceuticals Medicare Prescription Drugs Patient Affordability Negotiation Process Government Health Programs Access to Medicines Pharmaceutical Companies Cost of Medications Medications Market Demand 340B Drug Discount Program Rebates Insurance Coverage Cost Reduction FDA Programs Market Dynamics Most Favored Nation Policy Transparency Generic Medications Novo Nordisk Compounded Medications Insurance Policies Executive Orders Insurance Plans

States Curb Medicaid Coverage for GLP-1 Weight-Loss Drugs as Oral Wegovy and Discount Portals Debut

The changes highlight a widening gap between growing self-pay options versus contracting public coverage.

Stories older than 24h

FDA Names First 9 Drugs for ‘National Priority’ Fast-Track Reviews, Targeting 1–2-Month Decisions

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

FDA launches AI assistant Elsa early as staff flag readiness issues

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves